Amanda Souza Araújo1,2, Mara Rúbia Figueiredo1,2, Isabella Lomonaco3, Fernando Lundgren4, Rafael Mesquita5, Eanes Delgado Barros Pereira6. 1. Department of Surgery, Federal University of Ceara, Fortaleza, Ceará, Brazil. 2. Hospital Dr. Carlos Alberto Studart Gomes, Fortaleza, CE, Brasil. 3. Department of Medicine, Federal University of Ceara, Fortaleza, Ceará, 60140000, Brazil. 4. Hospital Otávio de Freitas, Recife, PE, Brasil. 5. Department of Physiotherapy, Federal University of Ceara, Fortaleza, Ceará, Brazil. 6. Department of Medicine, Federal University of Ceara, Fortaleza, Ceará, 60140000, Brazil. eanes@fortalnet.com.br.
Abstract
INTRODUCTION: Bronchiectasis is a chronic condition that is becoming a global health concern. OBJECTIVE: To examine the effects of pulmonary rehabilitation (PR) on systemic inflammation, exercise capacity, and quality of life in participants with bronchiectasis. METHODS: Participants were randomized to receive PR (outpatient, three weekly sessions for 3 months) or control intervention (usual care + airway clearance therapy + breathing exercises). Data on laboratory (fibrinogen level) and patient-centered outcomes such as physical fitness [6-min walk test (6MWT)] and quality of life were collected. RESULTS: A total of 41 participants were evaluated (20 in the intervention group and 21 in the control group). The magnitude of change between baseline and the end of study was greater in the PR group than in the control group-the 6MWT distance increased by a mean of 54 m (54 vs 12 m; p < 0.01), fibrinogen showed a significant reduction (fibrinogen - 92.8 versus - 47.1 mg/dl; p < 0.01), and quality of life improved according to Saint George's Respiratory Questionnaire (SGRQ) (- 7.5 vs 3.2; p < 0.01), which exceeded the minimal clinically important difference of 4 points. CONCLUSION: PR effectively improved physical fitness, quality of life, and the degree of systemic inflammation, as reflected by changes in 6 MWT, fibrinogen levels and SGRQ scores. This study supports the inclusion of people with bronchiectasis in supervised PR programs.
INTRODUCTION: Bronchiectasis is a chronic condition that is becoming a global health concern. OBJECTIVE: To examine the effects of pulmonary rehabilitation (PR) on systemic inflammation, exercise capacity, and quality of life in participants with bronchiectasis. METHODS: Participants were randomized to receive PR (outpatient, three weekly sessions for 3 months) or control intervention (usual care + airway clearance therapy + breathing exercises). Data on laboratory (fibrinogen level) and patient-centered outcomes such as physical fitness [6-min walk test (6MWT)] and quality of life were collected. RESULTS: A total of 41 participants were evaluated (20 in the intervention group and 21 in the control group). The magnitude of change between baseline and the end of study was greater in the PR group than in the control group-the 6MWT distance increased by a mean of 54 m (54 vs 12 m; p < 0.01), fibrinogen showed a significant reduction (fibrinogen - 92.8 versus - 47.1 mg/dl; p < 0.01), and quality of life improved according to Saint George's Respiratory Questionnaire (SGRQ) (- 7.5 vs 3.2; p < 0.01), which exceeded the minimal clinically important difference of 4 points. CONCLUSION: PR effectively improved physical fitness, quality of life, and the degree of systemic inflammation, as reflected by changes in 6 MWT, fibrinogen levels and SGRQ scores. This study supports the inclusion of people with bronchiectasis in supervised PR programs.
Authors: Suhani Patel; Aaron D Cole; Claire M Nolan; Ruth E Barker; Sarah E Jones; Samantha Kon; Julius Cairn; Michael Loebinger; Robert Wilson; William D-C Man Journal: Eur Respir J Date: 2019-01-17 Impact factor: 16.671
Authors: Emily Henkle; Benjamin Chan; Jeffrey R Curtis; Timothy R Aksamit; Charles L Daley; Kevin L Winthrop Journal: Chest Date: 2018-07-25 Impact factor: 9.410
Authors: Vijay N Joish; Monica Spilsbury-Cantalupo; Elisabeth Operschall; Ba Luong; Susan Boklage Journal: Appl Health Econ Health Policy Date: 2013-06 Impact factor: 2.561
Authors: Martijn A Spruit; Sally J Singh; Chris Garvey; Richard ZuWallack; Linda Nici; Carolyn Rochester; Kylie Hill; Anne E Holland; Suzanne C Lareau; William D-C Man; Fabio Pitta; Louise Sewell; Jonathan Raskin; Jean Bourbeau; Rebecca Crouch; Frits M E Franssen; Richard Casaburi; Jan H Vercoulen; Ioannis Vogiatzis; Rik Gosselink; Enrico M Clini; Tanja W Effing; François Maltais; Job van der Palen; Thierry Troosters; Daisy J A Janssen; Eileen Collins; Judith Garcia-Aymerich; Dina Brooks; Bonnie F Fahy; Milo A Puhan; Martine Hoogendoorn; Rachel Garrod; Annemie M W J Schols; Brian Carlin; Roberto Benzo; Paula Meek; Mike Morgan; Maureen P M H Rutten-van Mölken; Andrew L Ries; Barry Make; Roger S Goldstein; Claire A Dowson; Jan L Brozek; Claudio F Donner; Emiel F M Wouters Journal: Am J Respir Crit Care Med Date: 2013-10-15 Impact factor: 21.405